STOCK TITAN

Capital World Investors reports 0.2% Zai Lab (ZLAB) stake

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Capital World Investors, a division of Capital Research and Management Company and its affiliates, reports beneficial ownership of 1,723,600 shares of Zai Lab Ltd. common stock. This represents 0.2% of the 1,119,628,030 shares it believes are outstanding.

The firm has sole voting and dispositive power over these shares and no shared power. It states the position is held in the ordinary course of business and not for the purpose of changing or influencing control of Zai Lab, and that it owns less than five percent of the class.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



Capital World Investors
Signature:Timothy J. Moon
Name/Title:Vice President and Senior Counsel, Capital Research and Management Company
Date:02/10/2026

FAQ

What percentage of Zai Lab (ZLAB) does Capital World Investors report owning?

Capital World Investors reports owning 0.2% of Zai Lab’s common stock. This corresponds to beneficial ownership of 1,723,600 shares out of 1,119,628,030 shares it believes are outstanding, and reflects ownership of less than five percent of the class.

How many Zai Lab (ZLAB) shares does Capital World Investors beneficially own?

Capital World Investors beneficially owns 1,723,600 shares of Zai Lab common stock. The filing states it has sole voting and sole dispositive power over these shares, representing 0.2% of the 1,119,628,030 shares it believes are outstanding.

Does Capital World Investors seek to influence control of Zai Lab (ZLAB)?

No. Capital World Investors certifies the Zai Lab shares were acquired and are held in the ordinary course of business. It states they were not acquired and are not held to change or influence control of Zai Lab, consistent with a passive investment position.

What type of filing did Capital World Investors make regarding Zai Lab (ZLAB)?

Capital World Investors filed an amended Schedule 13G reporting its beneficial ownership in Zai Lab. Schedule 13G is used for passive holdings, and this amendment reflects its current position and confirms ownership of 5 percent or less of the class.

What voting and dispositive powers does Capital World Investors have over Zai Lab (ZLAB) shares?

Capital World Investors reports sole voting power and sole dispositive power over 1,723,600 Zai Lab shares. It reports no shared voting or shared dispositive power, indicating all reported authority over these shares rests solely with Capital World Investors.

Who signed the Zai Lab (ZLAB) Schedule 13G/A for Capital World Investors?

The filing was signed by Timothy J. Moon, identified as Vice President and Senior Counsel of Capital Research and Management Company. The signature section certifies, after reasonable inquiry, that the information provided about the Zai Lab holdings is true, complete, and correct.
Zai Lab Limited

NASDAQ:ZLAB

ZLAB Rankings

ZLAB Latest News

ZLAB Latest SEC Filings

ZLAB Stock Data

2.10B
106.96M
1.74%
42.53%
4.26%
Biotechnology
Pharmaceutical Preparations
Link
China
SHANGHAI